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Introduction
Mammographic screening has resulted in the increased
detection of invasive breast cancers as well as the detec-
tion of certain lesions regarded to be precursors of inva-
sive breast cancer (such as ductal carcinoma in situ
[DCIS]) and risk factors for the subsequent development
of breast cancer (such as atypical ductal hyperplasia
[ADH]). In addition, several breast lesions that were only
uncommonly seen in the premammographic era are cur-
rently being encountered with increasing frequency in
breast biopsies performed because of a mammographic
abnormality, particularly microcalcifications. Included
within this group are lesions that have recently been des-
ignated ‘flat epithelial atypia’ by the World Health Organi-
zation Working Group on the Pathology and Genetics of
Tumours of the Breast [1].
Classification and pathologic features
‘Flat epithelial atypia’ is better considered a descriptive
term that encompasses several different lesions, rather
than a specific pathologic diagnosis per se. Despite the
diversity of published descriptions and the wide assort-
ment of names applied to breast lesions that would cur-
rently be included in the category of flat epithelial atypia
[2–11] (Table 1), for practical purposes these lesions can
be grouped into one of two diagnostic categories: colum-
nar cell change with atypia or columnar cell hyperplasia
with atypia [12]. Although ‘flat epithelial atypia’ will be used
for purposes of discussion in the present review, we use
the more specific diagnostic terms ‘columnar cell change
with atypia’ and ‘columnar cell hyperplasia with atypia’ in
clinical practice and in surgical pathology reporting.
Columnar cell change with atypia
Columnar cell change with atypia is characterized by ter-
minal duct lobular units that display variably dilated acini
lined by one or two layers of epithelial cells that are colum-
nar in shape, although the height of these columnar cells
varies. Apical cytoplasmic blebs or snouts are often
present at the luminal surface of the epithelial cells and, in
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Abstract
Flat epithelial atypia is a descriptive term that encompasses lesions of the breast terminal duct lobular
units in which variably dilated acini are lined by one to several layers of epithelial cells, which are
usually columnar in shape and which display low-grade cytologic atypia. Observational studies have
suggested that at least some of these lesions may represent either a precursor of ductal carcinoma
in situ (DCIS) or the earliest morphological manifestation of DCIS. In contrast, the limited available
clinical follow-up data suggest that the risk of both local recurrence and progression of these lesions to
invasive cancer is extremely low, supporting the notion that categorizing such lesions as ‘clinging
carcinoma’ and managing them as if they were fully developed DCIS will result in overtreatment of
many patients. Additional studies are needed to better understand the biological nature and clinical
significance of these lesions.
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some cases, may be prominent or exaggerated, which may
impart an irregular contour to the luminal aspect of the
acini.
Flocculent secretions are often present in the acinar
lumina. In addition, the acini often contain luminal calcifica-
tions that may be irregular or may have the appearance of
psammoma bodies (Fig.1a). The cells lining the involved
acini show cytologic atypia, which is usually of low grade.
This atypia is characterized by the presence of columnar
epithelial cells with round to ovoid nuclei that are not regu-
larly oriented perpendicular to the basement membrane,
with a slight increase in the nuclear/cytoplasmic ratio. The
nuclear chromatin may be evenly dispersed or slightly mar-
ginated, and the nucleoli are variably prominent. Mitotic
figures may be seen but are uncommon (Fig.1b). In other
cases, the columnar cells may resemble the cells compris-
ing the tubules of tubular carcinoma. The cytologic atypia
in these cases may be quite subtle.
In some cases of columnar cell change with atypia, the
lesion may be overlooked entirely on low-power micro-
scopic examination due to the lack of significant cellular
proliferation and the subtle nature of the cytologic atypia
[8]. In fact, terminal duct lobular units exhibiting this alter-
ation are often misinterpreted on low-power microscopic
examination as either normal or as showing only micro-
cysts. It is only after examination of such foci under high
magnification that the subtle cytologic atypia becomes
evident.
Columnar cell hyperplasia with atypia
The term columnar cell hyperplasia with atypia is used to
describe lesions composed of terminal duct lobular units
with variably dilated acini lined by columnar cells that have
cytologic features similar to those seen in columnar cell
change with atypia but that also show cellular stratification
of more than two cell layers. The proliferating epithelial
cells may form small mounds, tufts or short micropapilla-
tions. However, complex architectural patterns, such as
well-developed micropapillations, rigid cellular bridges,
bars and arcades, or sieve-like fenestrations, with evi-
dence of cellular polarization within the micropapillations
and bars or around the fenestrations, are absent (Fig.2).
Thus, while these lesions are included under the heading
‘flat epithelial atypia’, it should be apparent that ‘flat’ is a
relative term, simply denoting the absence of complex
architectural patterns as described earlier. Exaggerated
apical cytoplasmic snouts and abundant flocculent intralu-
minal secretions are often present, and some of the cells
comprising such lesions may have a hobnail appearance.
These lesions frequently show intraluminal calcifications,
Table 1
Other names used to describe lesions within the category of
flat epithelial atypia
Description Reference
Atypical cystic duct [2]
Atypical cystic lobules [3]
Atypical lobules type A (some examples) [4]
Clinging carcinoma (monomorphic type) [5,6]
Columnar alteration with prominent apical snouts and [7]
secretions with atypia
Columnar cell change with atypiaa [12]
Columnar cell hyperplasia with atypiaa [12]
Ductal intraepithelial neoplasia of the flat monomorphic type [8]
Hypersecretory hyperplasia with atypia (some examples) [9]
Pretubular hyperplasia [10]




Flat epithelial atypia: columnar cell change with atypia. (a) This terminal duct lobular unit shows variably dilated acini, many of which contain
intraluminal secretions and calcifications. Most acini are lined by only one or two layers of columnar epithelial cells, many of which show prominent
apical cytoplasmic snouts (hematoxylin & eosin, original magnification 10×). (b) The columnar epithelial cells lining the acini show cytologic atypia,
characterized by enlarged, monotonous nuclei; the nuclear/cytoplasmic ratio is increased. Nucleoli are evident in some of the nuclei (hematoxylin &
eosin, original magnification 40×).265
which in some instances may have the configuration of
psammoma bodies.
High-grade cytologic atypia with nuclear pleomorphism of
the type seen in high-grade DCIS is not a feature of
lesions we include in the categories of columnar cell
change with atypia or of columnar cell hyperplasia with
atypia [12]. The presence of such high-grade nuclear fea-
tures merits the designation of high-grade DCIS, even if
the cells comprise only a single cell layer [6]. However,
such lesions are rarely seen in the absence of high-grade
DCIS exhibiting other architectural patterns.
It is important to note that while the flat lesions we have
designated columnar cell change with atypia and colum-
nar hyperplasia with atypia may be observed in isolation,
they often coexist with more complex proliferative lesions
that are composed of cytologically similar cells and that
fulfill the diagnostic criteria for ADH or DCIS. In fact, their
presence should prompt a diligent search for such areas.
Biological markers
Studies of the expression of various biological markers in
flat epithelial atypia are fairly limited. The available data
have indicated that the majority of the cells comprising
these lesions exhibit expression of cytokeratin 19 [13],
and they consistently lack expression of high molecular
weight cytokeratins as defined by antibody 34 beta E-12
and antibodies to cytokeratin 5 and cytokeratin 6 [14]
(Carlo V, Fraser J, Pliss N, Connolly JL, Schnitt S, unpub-
lished data, 2003). In addition, the cells typically show
intense nuclear expression of the estrogen receptor
[3,15,16] and the progesterone receptor [13] in the
majority of the cells. These cells also show strong cyto-
plasmic expression of the bcl-2 protein [15] and variable
expression of cyclin D1 [13]. In most examples of flat
epithelial atypia, very few of the cells show staining for the
Ki-67 antigen, indicating that the cells comprising these
lesions have a low proliferative rate [15].
Clinical significance
Assessment of the clinical significance of the flat epithelial
atypias has been hampered by variations in the terminol-
ogy used to describe these lesions and by the limited
number of cases that have been studied in a systematic
fashion. There have been two types of studies that have
addressed the potential clinical importance of these
lesions: observational studies and clinical outcome
studies.
Observational studies
A number of authors have noted that flat epithelial atypias
are often seen in association with DCIS and with some
types of invasive breast carcinoma, particularly tubular car-
cinoma. Oyama and colleagues studied 21 cases of the
flat lesion they termed “atypical cystic lobules” [3], and
found these lesions to be more common in specimens
containing DCIS than in specimens without DCIS (36%
versus 3%). They also noted geographic proximity
between the flat lesion and the DCIS. Weidner described
a lesion composed of small ectatic ducts lined by one or
two layers of columnar cells with apical snouts similar to
those seen in tubular carcinoma [17]. He considered this
flat lesion to represent an example of low-grade DCIS. In a
more detailed analysis, Goldstein and O’Malley found an
association between a similar lesion they called “small
ectatic ducts lined by atypical cells with apocrine snouts”
with both low-grade DCIS and tubular carcinoma [11].
Other authors have also noted an association between
various flat atypical lesions and DCIS and/or invasive car-
cinoma [4,9,10].
In addition, cytologic, immunophenotypic, and genetic simi-
larities between flat epithelial atypias and DCIS and/or
tubular carcinoma have been described by various authors.
Among 16 cases with both atypical cystic lobules and
low-grade DCIS, Oyama and colleagues noted that the
cells comprising the atypical cystic lobules were cytologi-
cally similar to the cells of the fully developed DCIS
present in the same specimen [3]. Other investigators
have also noted that the cells comprising some flat atypi-
cal lesions are cytologically similar to or identical to the
cells comprising some forms of DCIS or to the cells com-
prising the glands of tubular carcinoma [6,8,10,11,18].
Oyama and colleagues further noted an immunopheno-
typic identity between atypical cystic lobules and coexis-
tent low-grade DCIS (the cells of both lesions being
Available online http://breast-cancer-research.com/content/5/5/263
Figure 2
Flat epithelial atypia: columnar cell hyperplasia with atypia. The acini in
this terminal duct lobular unit are lined by a few layers of columnar
epithelial cells that show low-grade cytologic atypia, characterized by
relatively round, monotonous nuclei (hematoxylin & eosin, original
magnification 20×).266
positive for the estrogen receptor, the progesterone
receptor, keratin 19 and cyclin D1) in their 16 cases [3]. In
a recent genetic study of 13 cases of the flat atypical
lesion designated ‘DIN-flat monomorphic type’, Moinfar
and colleagues found that 70% showed loss of heterozy-
gosity at one or more of the eight loci evaluated [8]. Fur-
thermore, they found that the genetic alterations in these
columnar cell lesions were the same as those in the asso-
ciated DCIS or invasive cancer [8].
Based on the foregoing observations, it is reasonable to
conclude that at least some flat epithelial atypias are prob-
ably neoplastic proliferations that may well represent
either a precursor of or the earliest morphologic manifesta-
tion of low-grade DCIS, as well as being a precursor to
invasive carcinoma, particularly tubular carcinoma. While
this is of great interest from a biological point of view, the
clinical implications of these observations can only be
determined from follow-up studies. Unfortunately there is a
paucity of data on this subject, and the few available
studies are characterized by very small numbers of
patients.
Clinical outcome studies
Only two follow-up studies have directly addressed the
clinical significance of flat epithelial atypia to date. In a
review of more than 9000 breast biopsies that were ini-
tially considered benign, Eusebi and colleagues retrospec-
tively identified 25 patients with so-called “clinging
carcinoma” of the flat, monomorphic (low nuclear grade)
type [6]. Only one of these patients (4%) is reported to
have developed a ‘local recurrence’ after an average
follow-up period of 19.2 years. However, the local recur-
rence in this patient consisted of a clinging carcinoma
lesion histologically identical to the original lesion, and it is
not possible to determine whether this simply reflected
persistence of the original lesion due to inadequate exci-
sion or whether this represented a true local recurrence.
Of note, none of these 25 patients developed an invasive
breast cancer within the follow-up period.
In another study, 59 patients with clinging carcinoma of
the low nuclear grade type were identified among the
patients entered into European Organization for Research
and Treatment of Cancer trial 10853, a randomized clini-
cal trial comparing excision and radiation therapy with
excision alone for the treatment of women with DCIS [19].
None of these 59 patients developed a local recurrence or
an invasive breast cancer with a median follow-up period
of 5.4 years. The very limited available data thus suggest
that, among patients with so-called clinging carcinoma of
the low nuclear grade/monomorphic type (lesions that we
would categorize as columnar cell change with atypia or
columnar cell hyperplasia with atypia), the likelihood of
local recurrence or progression to invasive breast cancer
is exceedingly low, at least with the available follow-up
(Table 2). Additional clinical follow-up studies are clearly
needed, however, to better understand the relationship
between these flat epithelial atypias and the risk of subse-
quent breast cancer.
Practical considerations
The appropriate pathology work-up and clinical manage-
ment of patients whose biopsy specimens show flat
epithelial atypias are evolving as information regarding
these lesions begins to accumulate. The limited available
data suggest that when flat epithelial atypia is encoun-
tered in a core needle biopsy specimen, subsequent exci-
sion shows a more advanced lesion in about one-third of
cases. This is sufficiently frequent to recommend excision
in such cases as a matter of routine [20,21].
The presence of flat epithelial atypia in an excisional
biopsy specimen should prompt a careful search for areas
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Table 2
Outcome of patients with ‘clinging carcinoma’ (flat type, with low nuclear grade/monomorphic nuclei)
European Organization for Research and
Eusebi and colleagues [6] Treatment of Cancer Trial 10853 [19]
Number of patients 25 59
Type of study Retrospective review of breast biopsies Prospective, randomized clinical trial
originally considered benign
Treatment Diagnostic biopsy; no attempt at excision Excision alone or excision and radiation therapyb
Follow-up 19.2 years (mean) 5.4 years (median)
Number (%) with local recurrence 1 (4%)a 0
Number with subsequent invasive 0 0
breast cancer
aThe ‘local recurrence’ in this case consisted of a ‘clinging carcinoma’ lesion histologically identical to the original lesion. It is therefore not possible
to determine whether this simply reflects persistence of the original lesion due to inadequate excision or whether this represents a true local
recurrence. bNumber of patients in each treatment arm, with pure ‘clinging carcinoma’ arm not provided.267
with diagnostic features of ADH or DCIS, by examining
additional sections from the block or blocks containing the
lesion and by the submission of the remainder of the
tissue for histological examination. There are several other
considerations regarding the identification of flat epithelial
atypia in excisional biopsy specimens that merit discus-
sion. When a proliferation that fulfills the diagnostic criteria
for ADH or DCIS is found to arise in a background of flat
epithelial atypia, it seems most prudent to manage the
patient as one would manage ADH or DCIS in any other
setting. However, there are two issues that remain to be
resolved when the flat atypia is found to coexist with diag-
nostic areas of DCIS, particularly in cases in which the
cytologic features of the cells comprising the flat atypia
are similar to those of the cells comprising the diagnostic
areas of DCIS. The first issue is whether the flat atypia
should be taken into consideration in determining the size
or the extent of the DCIS lesion. The second is whether
the presence of flat atypia at the excision margins is suffi-
cient to render the margins ‘positive’, requiring further sur-
gical resection. As noted earlier, the limited available
clinical data suggest that flat atypias are associated with a
very low risk of recurrence or progression to invasive car-
cinoma. Therefore, we believe that these lesions should
not be taken into consideration when determining the size
of a coexistent DCIS lesion or in the evaluation of the
status of the margins of excision, even when they are com-
posed of cells that are cytologically similar to those in the
diagnostic areas of DCIS [12].
Another problem is the management of patients whose
breast biopsies, after thorough examination, show flat
epithelial atypia (columnar cell change with atypia and/or
columnar cell hyperplasia with atypia) without diagnostic
areas of ADH or DCIS. Again, pathologists that consider
these flat lesions to represent ‘cancerization of lobules’ by
the cells of low-grade DCIS or ‘clinging carcinoma’ would
argue that they should be considered variants of DCIS,
and managed as such [11]. Others would argue that,
despite the fact that these flat lesions may well be neo-
plastic and may even be composed of cells that are identi-
cal to those seen in some forms of DCIS or even tubular
carcinoma, the few available clinical follow-up studies
suggest that they are associated with a risk of subsequent
breast cancer that is considerably lower than that seen
with fully developed forms of low-grade DCIS. The
concern, therefore, is that managing patients with such
lesions as if they had DCIS would result in overtreatment
of many patients.
Conclusions
Lesions included within the category of flat epithelial
atypia (i.e. lesions that we currently designate columnar
cell change with atypia and columnar cell hyperplasia with
atypia) are being encountered with increasing frequency
due to the widespread use of screening mammography.
Recent studies have begun to provide insights into the
biological and clinical significance of these lesions.
However, additional morphologic, immunophenotypic and
genetic studies are needed to better define the relation-
ships between these flat atypical lesions to DCIS and
invasive breast cancer. Emerging data suggest that these
flat epithelial atypias may be neoplastic lesions that repre-
sent the earliest form of low-grade DCIS. Despite this, the
limited available clinical follow-up data suggest that the
risk of local recurrence or progression of these lesions to
invasive cancer is quite low, supporting the notion that
categorizing such lesions as ‘clinging carcinoma’ and
managing them as if they were fully developed DCIS will
result in overtreatment of many patients. Thus, at this time,
the appropriate management of patients whose breast
biopsies show flat epithelial atypia in the absence of diag-
nostic areas of ADH or DCIS is unknown and requires
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